• R Vicente, I Moreno, A Soria, F Ramos, and S Torregrosa.
• Servicio de Anestesiología-Reanimación, Hospital Universitario La Fe, Valencia, Spain. ro.vicenteg@comv.es
• Med Intensiva. 2013 Mar 1;37(2):110-5.

AbstractThe use of extracorporeal techniques in cardiopulmonary support has spread in the last 20 years. ECMO (extracorporeal membrane oxygenation) devices are the most commonly employed option, and have been used for years in lung transplant programs. Nevertheless, few articles on the results of ECMO involving large numbers of cases have been published to date. The use of ECMO in respiratory failure affords immediate oxygen support in patients with severe hypoxia and/or acidosis, and moreover provides pulmonary protection, since it allows an instantaneous decrease in the ventilator pressure and FiO2 needs. The complications of ECMO have been minimized thanks to the technological improvements found in the latest devices, though renal failure, infections, bleeding, and vascular and mechanical complications are still reported in many studies. At present there is less controversy regarding the use of cardiorespiratory assists with ECMO as an alternative in decompensated patients who are on the waiting list, referred to the intra- and postoperative periods of lung transplantation.Copyright © 2012 Elsevier España, S.L. and SEMICYUC. All rights reserved.

6 keywords...

hide…